HIGHLIGHTS OF PRESCRIBING INFORMATION

First Page		Document Content
Date: 2015-03-26 19:23:33 Anilides Ertapenem Pyrrolidines Piperazines Clostridium difficile Omeprazole Valproic acid Anakinra Flucytosine Chemistry Organic chemistry Pharmacology		HIGHLIGHTS OF PRESCRIBING INFORMATION Add to Reading List Source URL: www.merck.com Download Document from Source Website File Size: 467,12 KB Share Document on Facebook

	2017 年 12 月 20 放送｢Clostridium difficile 感染症の重症度分類｣愛知医科大学病院感染症科特任教授 DocID: 1v6YB - View Document
	CLOSTRIDIUM DIFFICILE HOSPITALIZATIONS Table of Contents Introduction ................................................................................................................................ 1 General DocID: 1uRec - View Document
	MCB3681 – the only intravenous treatment in clinical development for Clostridium difficile infections Morphochem AG Gmunderstr. 37 AMunich Germany ECCMID 9-12 April 2016 DocID: 1uFyL - View Document
	La transplantation fécale dans l’infection à Clostridium difficile : quelle place en gériatrie ? Dr Catherine Eckert Dr Frédéric Barbut Laboratoire associé C. difficile, Paris GRC n°2 EPIDIFF, UPMC DocID: 1ukMR - View Document
	Clostridium difficile Infections Reporting in Illinois Acute Care Hospitals, 2013 As of January 1, 2012, all Illinois hospitals began mandated reporting of blood cultures positive for Clostridium difficile Infections (CD DocID: 1sySJ - View Document